These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14997914)

  • 41. Preventing post-ERCP pancreatitis: where are we?
    Testoni PA
    JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial.
    Wang ZK; Yang YS; Cai FC; Wang YH; Shi XL; Ding C; Li W
    Chin Med J (Engl); 2013 Jul; 126(13):2403-8. PubMed ID: 23823808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial.
    Poon RT; Yeung C; Lo CM; Yuen WK; Liu CL; Fan ST
    Gastrointest Endosc; 1999 May; 49(5):593-8. PubMed ID: 10228257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prophylactic effect of somatostatin in preventing Post-ERCP pancreatitis: an updated meta-analysis.
    Qin X; Lei WS; Xing ZX; Shi F
    Saudi J Gastroenterol; 2015; 21(6):372-8. PubMed ID: 26655132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography.
    Schneider J; Barkin J
    Gastrointest Endosc; 1997 May; 45(5):447-8. PubMed ID: 9165340
    [No Abstract]   [Full Text] [Related]  

  • 46. Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial.
    Concepción-Martín M; Gómez-Oliva C; Juanes A; Díez X; Prieto-Alhambra D; Torras X; Sainz S; Villanueva C; Farre A; Guarner-Argente C; Guarner C
    Endoscopy; 2014 Oct; 46(10):851-6. PubMed ID: 24977398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preventive effect of ulinastatin and gabexate mesylate on post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Zhang ZF; Yang N; Zhao G; Zhu L; Zhu Y; Wang LX
    Chin Med J (Engl); 2010 Sep; 123(18):2600-6. PubMed ID: 21034635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
    Dumonceau JM; Andriulli A; Elmunzer BJ; Mariani A; Meister T; Deviere J; Marek T; Baron TH; Hassan C; Testoni PA; Kapral C;
    Endoscopy; 2014 Sep; 46(9):799-815. PubMed ID: 25148137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of ulinastatin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: the Emperor's New Clothes or Aladdin's Magic Lamp?
    Chen S; Shi H; Zou X; Luo H
    Pancreas; 2010 Nov; 39(8):1231-7. PubMed ID: 20531245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How to Avoid Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Leerhøy B; Elmunzer BJ
    Gastrointest Endosc Clin N Am; 2018 Oct; 28(4):439-454. PubMed ID: 30241637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events: post-ERCP pancreatitis.
    Rustagi T; Jamidar PA
    Gastrointest Endosc Clin N Am; 2015 Jan; 25(1):107-21. PubMed ID: 25442962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological management of pancreatitis.
    Hoogerwerf WA
    Curr Opin Pharmacol; 2005 Dec; 5(6):578-82. PubMed ID: 16198632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of somatostatin on hyperamylasemia following endoscopic pancreatography.
    Tydén G; Nyberg B; Sonnenfeld T; Thulin L
    Acta Chir Scand Suppl; 1986; 530():43-5. PubMed ID: 2425529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
    Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
    Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of nonsteroidal anti-inflammatory drugs in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
    Sheikh I; Fontenot E; Waghray N; Ismail MK; Tombazzi C; Smith JL
    JOP; 2014 May; 15(3):219-24. PubMed ID: 24865531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preventing Postendoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Elmunzer BJ
    Gastrointest Endosc Clin N Am; 2015 Oct; 25(4):725-36. PubMed ID: 26431600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can we prevent post-ERCP pancreatitis?
    Siiki A; Laukkarinen J
    Duodecim; 2017; 133(3):267-74. PubMed ID: 29205025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Bai Y; Gao J; Shi X; Zou D; Li Z
    Pancreatology; 2008; 8(4-5):504-9. PubMed ID: 18765955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative study of strategies for preventing post-ERCP pancreatitis after early precut sphincterotomy for biliary access.
    Ang TL; Kwek AB; Song M; Li JW; Thurairajah PH
    J Dig Dis; 2016 Oct; 17(10):692-696. PubMed ID: 27556283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial.
    Bai Y; Ren X; Zhang XF; Lv NH; Guo XG; Wan XJ; Nie ZG; Han ST; Bie P; Tian DA; Ji M; Li ZS
    Endoscopy; 2015 May; 47(5):415-20. PubMed ID: 25590178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.